EU humiliation: Investigation into AstraZeneca backfired as company told truth on vaccine

Vaccine row: European Union warned about contracts by Wallace

When you subscribe we will use the information you provide to send you these newsletters.Sometimes they’ll include recommendations for other related newsletters or services we offer.Our Privacy Notice explains more about how we use your data, and your rights.You can unsubscribe at any time.

Leaders in Brussels have raged at the pharmaceutical company in recent months as vaccines come in short supply in Europe. The delay of the vaccine rollout comes as hospitals in Germany warn they are reaching their limits. Doctors warned that hospitals could reach “breaking point” in April as daily cases could more than double. Health Minister in Berlin, Jens Spahn, said during a conference: “If we look at the numbers, we need 10-14 days at least of properly driving down contact and movement.

“A lockdown if you want to call it that.”

The EU insists that AstraZeneca made different and contradictory promises to Brussels and to the UK in their respective contracts, signed last year.

An EU diplomat told the BBC earlier this month: “AstraZeneca appears to have promised the UK priority for the first X million doses – using production facilities in the EU, as well as the UK. This doesn’t add up. Though this isn’t the UK’s fault.”

Tensions between the EU and AstraZeneca heightened in January when Belgian authorities inspected a factory at the request of the European Commission.

Daniel Boffey, The Guardian’s Brussels bureau chief, outlined the row on the Today in Focus Podcast in February.

He said: “The chief executive of AstraZeneca did an interview in January, and he said there was a filtering problem.

“Since then, Belgian authorities have gone into the plant, this is how toxic it is, to see if AstraZeneca is lying or not.

“The officials went in, then they came out and said ‘there is a production problem’ – they talked about there being a lack of raw materials.”

When asked how the EU reacted to AstraZeneca’s claims of short supply, Mr Boffey replied: “Blind fury.”

He continued: “EU officials were astonished, appalled, hopping mad. I physically saw some hopping madness. They went very public with it as well.

“European Commissioner for Health Stella Kyriakides did a press conference, she was practically shaking, her voice was slightly wobbly.”

Despite recent clashes between the EU and UK, Brussels and London could be nearing a vaccine deal in an attempt to settle the ongoing feud.

Under the agreement the EU will remove its threat to block specific vaccine shipments to countries with higher vaccination rates or that do not export vaccines to the EU.

DON’T MISS
Brexit fury: EU fined UK £2.4billion in fraud row [INSIGHT]
Von Der Leyen ‘has caused serious crisis’ as EU unity crumbles [ANALYSIS]
EU vaccine crisis: Brussels’ actions ‘border on shameless’ [INSIGHT]

In return, the UK Government will agree to forgo some long-term supplies of the AstraZeneca vaccine that had been due to be exported from a factory in Holland run by the company’s subcontractor Halix.

Top diplomatic sources told The Times that the behind-the-scenes talks had helped restore trust despite rising tensions in public rhetoric.

One EU diplomat said: “For us it was very significant that Johnson did not use Frost but instead went through the Foreign Office.

“It showed that he was really serious about finding a compromise and trying to build trust.”

Source: Read Full Article